News

Ozempic sales surge as priced-out Mounjaro patients seek cheaper alternative

Ozempic sales have risen five-fold after a 126 per cent rise in the price of the Mounjaro drug due to pressure from US ...

Mounjaro rivals Wegovy and Retatrutide explained as price hiked for millions of users

Many Mounjaro users are looking into alternative medications following news of a 170 percent price increase in the UK ...

Wegovy becomes first GLP-1RA to gain FDA MASH approval

The drug received accelerated approval for use in patients with metabolic dysfunction-associated steatohepatitis (MASH).
BioPharma Dive1h

Novo’s Wegovy becomes first GLP-1 drug approved for MASH

The FDA clearance sets Novo’s medicine up a market battle with Madrigal Pharmaceuticals’ fast-selling Rezdiffra.

Rival fat jab WON’T increase in price, makers pledge – as Mounjaro set to double in costs

MAKERS of the fat jab Wegovy say they will not increase the price of the drug when the cost of rival Mounjaro doubles next ...

Weight-loss drug Wegovy launches in South Africa

The launch marked Danish drugmaker Novo Nordisk's debut on the continent, ramping up competition with rival Eli Lilly.

Novo Nordisk debuts Wegovy in South Africa as weight-loss drugs race gathers pace

Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...

Novo Nordisk Shares Rise After FDA Approves Wegovy for Liver Disease

Novo Nordisk shares climbed after the U.S. Food and Drug Administration approved a new indication for the Danish drugmaker’s ...
Medical Dialogues9d

Mounjaro, Wegovy sales in India double on month in July

Hyderabad: Sales of weight-loss drugs Wegovy by Danish pharmaceutical giant Novo Nordisk and Mounjaro by U.S.-based Eli Lilly ...

Shares in Novo Nordisk rise after Wegovy gets US nod for liver disease treatment

Shares in Novo Nordisk rose on Monday, after it got U.S. approval for its weight-loss drug Wegovy to treat a serious liver ...